M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Eleni T TzavaraGeorge G Nomikos

Abstract

Dopaminergic dysfunction is an important pathogenetic factor for brain pathologies such as Parkinson's disease, ADHD, schizophrenia, and addiction as well as for metabolic disorders and anorexia. Dopaminergic neurons projecting from the midbrain to forebrain regions, such as the nucleus accumbens and the prefrontal cortex, regulate motor and cognitive functions and coordinate the patterned response of the organism to sensory, affective, and rewarding stimuli. In this study, we showed that dopaminergic neurotransmission is highly dependent on M4 cholinergic muscarinic receptor function. Using in vivo microdialysis, we found elevated dopamine (DA) basal values and enhanced DA response to psychostimulants in the nucleus accumbens of M4 knockout mice. We also demonstrated impaired homeostatic control of cholinergic activity that leads to increased basal acetylcholine efflux in the midbrain of these animals. Thus, loss of M4 muscarinic receptor control of cholinergic function effectuates a state of dopaminergic hyperexcitability. This may be responsible for pathological conditions, in which appetitive motivation as well as affective and cognitive processing is impaired. We propose that M4 receptor agonists could represent an innovat...Continue Reading

References

May 1, 1992·The Journal of Physiology·S W Johnson, R A North
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D M WeinerM R Brann
Feb 1, 1995·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J S Yeomans
Sep 23, 1994·Science·A M GraybielM Kimura
Jan 1, 1996·Critical Reviews in Neurobiology·J Wess
Nov 25, 1996·Neuroreport·M T RothH A Baghdoyan
Dec 24, 1997·Brain Research. Molecular Brain Research·K SugayaM McKinney
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·J GomezaJ Wess
Jul 23, 1999·Annals of the New York Academy of Sciences·J F McGinty
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·J GomezaJ Wess
Dec 11, 1999·Psychopharmacology·T S ShippenbergV Chefer
Dec 23, 1999·Current Opinion in Neurobiology·S T KitaiR Scroggs
Feb 17, 2000·Trends in Neurosciences·P CalabresiG Bernardi
Jul 8, 2000·European Journal of Pharmacology·P Izurieta-SánchezY Michotte
Aug 26, 2000·European Journal of Pharmacology·T RasmussenA Fink-Jensen
Jun 8, 2001·Life Sciences·C C FelderD L McKinzie
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·D J GerberS Tonegawa
Aug 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Anthony S BasileJurgen Wess
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·Frank P BymasterDavid McKinzie

❮ Previous
Next ❯

Citations

Dec 17, 2009·Psychopharmacology·Morgane ThomsenS Barak Caine
Mar 5, 2011·Psychopharmacology·Lene S SchmidtAnders Fink-Jensen
Dec 19, 2012·Psychiatry Research·Roger B VarelaJoão Quevedo
Nov 27, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Katie LeachArthur Christopoulos
Jan 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Segev Barak, Ina Weiner
Oct 1, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carrie K JonesMichael Bubser
Aug 6, 2008·Proceedings of the National Academy of Sciences of the United States of America·W Y ChanC C Felder
Jul 10, 2007·Schizophrenia Bulletin·John A Gray, Bryan L Roth
Sep 6, 2008·The Journal of Pharmacology and Experimental Therapeutics·Ashley E BradyCraig W Lindsley
Aug 29, 2009·Cell Communication and Signaling : CCS·Rodrigo R Resende, Avishek Adhikari
Feb 12, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jongrye JeonJürgen Wess
Mar 6, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sarah ThrelfellStephanie J Cragg
Jan 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Julie Le MerrerBrigitte L Kieffer
Oct 29, 2015·Proceedings of the National Academy of Sciences of the United States of America·Tristano PancaniP Jeffrey Conn
Jan 3, 2012·Pharmacology, Biochemistry, and Behavior·Philipp Singer, Benjamin K Yee
Apr 17, 2007·Neuropharmacology·Stéphanie WeissMarie-Pascale Martres
Aug 23, 2012·Neuroscience and Biobehavioral Reviews·Suzanne J ReevesRobert J Howard
May 25, 2015·Neuroscience and Biobehavioral Reviews·Sean P CarruthersSusan L Rossell
Feb 1, 2017·ACS Chemical Neuroscience·Aaron M BenderCraig W Lindsley
Aug 30, 2010·Pharmaceuticals·Jan Jakubík, Esam E El-Fakahany
Jul 7, 2018·Brain and Behavior·Paulina ValuskovaJaromir Myslivecek
Sep 1, 2007·Nature Reviews. Drug Discovery·Jürgen WessDinesh Gautam
Apr 8, 2010·CNS Neuroscience & Therapeutics·Deranda B LesterCharles D Blaha
Dec 6, 2006·Molecular Psychiatry·T J RaedlerB Dean
Jan 21, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nellie E ByunCarrie K Jones
Jul 18, 2006·Neurochemical Research·Daniel B McClatchyAllan I Levey
Sep 28, 2018·CNS Drugs·Kevin P JensenMehmet Sofuoglu
Jan 23, 2018·Physiological Research·J MyslivecekP Valuskova
Feb 16, 2013·Expert Opinion on Investigational Drugs·Tiago A MestreSusan H Fox
Mar 30, 2017·Inflammopharmacology·Anil KumarDinesh K Dhull
May 8, 2018·Nature Medicine·Kallia ApazoglouEleni T Tzavara
Feb 23, 2020·Biomolecules·Jan Jakubik, Esam E El-Fakahany

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

© 2022 Meta ULC. All rights reserved